HCID 86588376, compound → HCID 86588377, compound

HRID 2301631Notes

Reaction equation

HRID 2301631 reaction equation
[O:1]1[CH2:5][CH2:4][CH2:3][N:2]1[C:6]1[CH:11]=[C:10]([Cl:12])[C:9]([S:13]([NH2:16])(=[O:15])=[O:14])=[C:8]([OH:17])[C:7]=1[N+:18]([O-])=O.[H][H]>[Pd]>[O:1]1[CH2:5][CH2:4][CH2:3][N:2]1[C:6]1[CH:11]=[C:10]([Cl:12])[C:9]([S:13]([NH2:16])(=[O:14])=[O:15])=[C:8]([OH:17])[C:7]=1[NH2:18]

Participants

4

Procedure

Following the general hydrogenation procedure outlined in example 15, (N-isoxazolidinyl)-6-chloro-2-hydroxy-3-nitrobenzenesulfonamide (0.84 g, 2.7 mmol) was reduced with hydrogen and 10% Pd/C (0.84 g) to form the desired product (0.75 g crude). LC-MS m/z 279(M+).

Sources & evidence

ORD record
ord-6a13526e97934945a260c9ffb49c2085
Source dataset
uspto-grants-2002_12
Patent number
US06500863B1

Reaction notes

Loading…